LCEV released in the sera of patients with NHL were enriched in CD19 and CD20 [39], while EVs isolated from patients with HL were enriched in the tumor-related antigen CD30, also known as tumor necrosis factor receptor 8 (TNFR8). The gene discussed is TNFRSF8; the disease is Hodgkins lymphoma.